Skip to main content

Gabriela Urcuyo Delgado

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Gabriela Urcuyo Delgado

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The donation will enable further characterisation of patients with this rare disease, the identification of new biomarkers and the exploration of innovative therapies.

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Related professionals

Anais Ramon Mulet

Anais Ramon Mulet

Directorate of Innovation and Business Development
Read more
Antonia Pijuan Domenech

Antonia Pijuan Domenech

Predoctoral researcher
Cardiovascular Diseases
Read more
Gemma Pérez Morte

Gemma Pérez Morte

Reconstructive Surgery of the Locomotor System
Read more
Manuel Ramirez Valencia

Manuel Ramirez Valencia

Predoctoral researcher
Spine Research Unit
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.